Global and Region Oral Contrast Agent Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Oral Contrast Agent market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Oral Contrast Agentmarket, defines the market attractiveness level of Oral Contrast Agent market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Oral Contrast Agent industry, describes the types of Oral Contrast Agent market, the applications of major players and the market size, and deeply analyzes the current situation of the global Oral Contrast Agent market and the development prospects and opportunities of Oral Contrast Agent industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Oral Contrast Agent market in Chapter 13.

    By Player:

    • Taejoon Pharm (South Korea)

    • JB Chemicals and Pharmaceuticals (India)

    • Bracco Imaging (Italy)

    • Guerbet (France)

    • Lantheus (US)

    • GE Healthcare (US)

    • Unijules Life Sciences (India)

    • Jodas (India)

    • Bayer HealthCare (Germany)

    • Daiichi Sankyo (Japan)

    • Magnus Health (India)

    • Spago Nanomedicine (Sweden)

    By Type:

    • Barium-based Contrast Media

    • Iodinated Contrast Media

    • Gadolinium-based Contrast Media

    • Microbubble Contrast Media

    By End-User:

    • Cardiovascular Disorders

    • Cancer

    • Gastrointestinal Disorders

    • Musculoskeletal Disorders

    • Neurological Disorders

    • Nephrological Disorders

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Oral Contrast Agent Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Oral Contrast Agent Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Oral Contrast Agent Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Oral Contrast Agent Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Oral Contrast Agent Market Analysis and Outlook to 2022

    • 7.1 Global Oral Contrast Agent Consumption (2017-2022)

    • 7.2 United States Oral Contrast Agent Consumption (2017-2022)

    • 7.3 Europe Oral Contrast Agent Consumption (2017-2022)

    • 7.4 China Oral Contrast Agent Consumption (2017-2022)

    • 7.5 Japan Oral Contrast Agent Consumption (2017-2022)

    • 7.6 India Oral Contrast Agent Consumption (2017-2022)

    • 7.7 South Korea Oral Contrast Agent Consumption (2017-2022)

    8 Region and Country-wise Oral Contrast Agent Market Analysis and Outlook to 2028

    • 8.1 Global Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.2 United States Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.3 Europe Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.4 China Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.5 Japan Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.6 India Oral Contrast Agent Consumption Forecast (2022-2028)

    • 8.7 South Korea Oral Contrast Agent Consumption Forecast (2022-2028)

    9 Global Oral Contrast Agent Market Outlook by Types and Applications to 2022

    • 9.1 Global Oral Contrast Agent Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)

    • 9.2 Global Oral Contrast Agent Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Neurological Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Nephrological Disorders Consumption and Growth Rate (2017-2022)

    10 Global Oral Contrast Agent Market Outlook by Types and Applications to 2028

    • 10.1 Global Oral Contrast Agent Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Oral Contrast Agent Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)

    11 Global Oral Contrast Agent Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Oral Contrast Agent Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Oral Contrast Agent Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Oral Contrast Agent Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Oral Contrast Agent Market Competitive Analysis

    • 14.1 Taejoon Pharm (South Korea)

      • 14.1.1 Taejoon Pharm (South Korea) Company Details

      • 14.1.2 Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Taejoon Pharm (South Korea) Oral Contrast Agent Product and Service

    • 14.2 JB Chemicals and Pharmaceuticals (India)

      • 14.2.1 JB Chemicals and Pharmaceuticals (India) Company Details

      • 14.2.2 JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product and Service

    • 14.3 Bracco Imaging (Italy)

      • 14.3.1 Bracco Imaging (Italy) Company Details

      • 14.3.2 Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bracco Imaging (Italy) Oral Contrast Agent Product and Service

    • 14.4 Guerbet (France)

      • 14.4.1 Guerbet (France) Company Details

      • 14.4.2 Guerbet (France) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Guerbet (France) Oral Contrast Agent Product and Service

    • 14.5 Lantheus (US)

      • 14.5.1 Lantheus (US) Company Details

      • 14.5.2 Lantheus (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Lantheus (US) Oral Contrast Agent Product and Service

    • 14.6 GE Healthcare (US)

      • 14.6.1 GE Healthcare (US) Company Details

      • 14.6.2 GE Healthcare (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 GE Healthcare (US) Oral Contrast Agent Product and Service

    • 14.7 Unijules Life Sciences (India)

      • 14.7.1 Unijules Life Sciences (India) Company Details

      • 14.7.2 Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Unijules Life Sciences (India) Oral Contrast Agent Product and Service

    • 14.8 Jodas (India)

      • 14.8.1 Jodas (India) Company Details

      • 14.8.2 Jodas (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Jodas (India) Oral Contrast Agent Product and Service

    • 14.9 Bayer HealthCare (Germany)

      • 14.9.1 Bayer HealthCare (Germany) Company Details

      • 14.9.2 Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Bayer HealthCare (Germany) Oral Contrast Agent Product and Service

    • 14.10 Daiichi Sankyo (Japan)

      • 14.10.1 Daiichi Sankyo (Japan) Company Details

      • 14.10.2 Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Daiichi Sankyo (Japan) Oral Contrast Agent Product and Service

    • 14.11 Magnus Health (India)

      • 14.11.1 Magnus Health (India) Company Details

      • 14.11.2 Magnus Health (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Magnus Health (India) Oral Contrast Agent Product and Service

    • 14.12 Spago Nanomedicine (Sweden)

      • 14.12.1 Spago Nanomedicine (Sweden) Company Details

      • 14.12.2 Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Spago Nanomedicine (Sweden) Oral Contrast Agent Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Oral Contrast Agent

    • Figure Oral Contrast Agent Picture

    • Table Global Oral Contrast Agent Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Contrast Agent Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Oral Contrast Agent Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Oral Contrast Agent Consumption by Country (2017-2022)

    • Figure United States Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Table Europe Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure China Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Japan Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure India Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure South Korea Oral Contrast Agent Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Contrast Agent Consumption Forecast by Country (2022-2028)

    • Figure United States Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Oral Contrast Agent Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Barium-based Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Iodinated Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Gadolinium-based Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Microbubble Contrast Media Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Musculoskeletal Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Nephrological Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Barium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Iodinated Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gadolinium-based Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Microbubble Contrast Media Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cardiovascular Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Musculoskeletal Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nephrological Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Oral Contrast Agent Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Oral Contrast Agent Export by Region (Top 5 Countries) (2017-2028)

    • Table Taejoon Pharm (South Korea) (Foundation Year, Company Profile and etc.)

    • Table Taejoon Pharm (South Korea) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Taejoon Pharm (South Korea) Oral Contrast Agent Product and Service

    • Table JB Chemicals and Pharmaceuticals (India) (Foundation Year, Company Profile and etc.)

    • Table JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table JB Chemicals and Pharmaceuticals (India) Oral Contrast Agent Product and Service

    • Table Bracco Imaging (Italy) (Foundation Year, Company Profile and etc.)

    • Table Bracco Imaging (Italy) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bracco Imaging (Italy) Oral Contrast Agent Product and Service

    • Table Guerbet (France) (Foundation Year, Company Profile and etc.)

    • Table Guerbet (France) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guerbet (France) Oral Contrast Agent Product and Service

    • Table Lantheus (US) (Foundation Year, Company Profile and etc.)

    • Table Lantheus (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lantheus (US) Oral Contrast Agent Product and Service

    • Table GE Healthcare (US) (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare (US) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare (US) Oral Contrast Agent Product and Service

    • Table Unijules Life Sciences (India) (Foundation Year, Company Profile and etc.)

    • Table Unijules Life Sciences (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Unijules Life Sciences (India) Oral Contrast Agent Product and Service

    • Table Jodas (India) (Foundation Year, Company Profile and etc.)

    • Table Jodas (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jodas (India) Oral Contrast Agent Product and Service

    • Table Bayer HealthCare (Germany) (Foundation Year, Company Profile and etc.)

    • Table Bayer HealthCare (Germany) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer HealthCare (Germany) Oral Contrast Agent Product and Service

    • Table Daiichi Sankyo (Japan) (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo (Japan) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo (Japan) Oral Contrast Agent Product and Service

    • Table Magnus Health (India) (Foundation Year, Company Profile and etc.)

    • Table Magnus Health (India) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Magnus Health (India) Oral Contrast Agent Product and Service

    • Table Spago Nanomedicine (Sweden) (Foundation Year, Company Profile and etc.)

    • Table Spago Nanomedicine (Sweden) Oral Contrast Agent Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spago Nanomedicine (Sweden) Oral Contrast Agent Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.